VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
ANIP
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
ANIPANI Pharmaceuticals, Inc.
$74.43$1.7B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksANIPQuarterly Cash Flow

ANI Pharmaceuticals, Inc. (ANIP) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

ANI Pharmaceuticals, Inc. (ANIP) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

ANIP Cash Flow Statement

Quarterly statement

ANIP Cash Flow Statement

ANI Pharmaceuticals, Inc. (ANIP) cash flow statement — 28-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Cash from Operations56.67M58.38M30.37M44.05M75.81M34.99M15.86M12.47M17.41M18.27M44.74M32.17M20.63M21.42M-4.4M3.62M-11.48M-18.94M-12.19M-5.4M
Operating CF Margin %21.3%24.58%12.29%19.34%35.87%17.75%8.32%8.41%12.62%13.29%33.98%24.4%17.7%20.06%-4.67%4.32%-15.55%-29.38%-20%-10.38%
Operating CF Growth %-25.25%66.83%91.47%253.17%335.35%91.53%-64.55%-61.22%-15.57%-14.73%1116.82%787.91%279.61%213.1%63.89%167.07%-4865.15%-191.65%-113.43%-234.7%
Net Income26.77M27.43M27.49M26.62M8.55M15.68M-10.28M-24.17M-2.29M18.21M1.16M9.94M6.25M1.44M-4.24M-8.6M-14.92M-20.13M-24.14M-4.45M
Depreciation & Amortization19.64M20.92M22.61M22.63M23.28M22.89M22.6M15.75M14.7M14.69M15.19M15.21M14.69M14.7M15.57M15.35M14.17M14.56M13.68M11.35M
Stock-Based Compensation21.6M09.77M9.69M9.6M8.87M7.06M7.48M7.86M6.93M5.62M5.44M5.25M4.34M3.74M3.87M3.76M3.24M2.97M2.81M
Deferred Taxes-4.94M2.52M2.36M18.8M-3.54M-3.38M-17.53M-5.59M-1.9M3.1M-8.35M-3.26M-910K773K-1.63M-2.25M-3.91M-7.46M-8.09M-1.99M
Other Non-Cash Items-12.8M7.13M-5.01M-15.85M1.68M-10.39M18.79M10.67M3.54M-14.44M3.32M-731K2.08M1.95M2.92M4.62M-283K1.74M3.3M577K
Working Capital Changes6.4M382K-26.85M-17.84M36.24M1.33M-4.78M8.33M-4.5M-10.22M27.8M5.57M-6.73M-1.77M-20.76M-9.37M-10.29M-10.88M84K-13.7M
Change in Receivables-19.08M25.53M-27.86M-26.96M-5.49M1.78M-25.51M8.44M6.33M-10.34M16.76M-5.92M1.79M-9.28M-25M9.98M-18.79M-3.1M5.37M-14.07M
Change in Inventory305K-437K3.73M-8.16M-908K-625K-675K-6.36M-11.61M-2.64M-4.61M-2.27M-669K1.7M-9.46M-3.31M-9.39M-1.46M-5.55M5.95M
Change in Payables-1.12M5.36M-7.24M13.77M3.08M5.55M-6.82M-3.08M-1.15M11.53M2.78M5.57M-3.9M3.1M10.06M-9.07M5.06M-1.01M9.77M-1.29M
Cash from Investing-3.05M-11.32M-1.4M-6.16M-6.91M-19.85M-10.68M-398.52M-4.45M8.93M-4.78M-4.55M-6.83M-2.35M-3.14M-9.81M-604K-2.18M-82.21M-583K
Capital Expenditures6.07M-6.07M-9.38M-6.1M-4.01M-2.47M-2.39M-4.81M-4.45M-4.58M-2.28M-1.74M-2.5M-2.35M-3.14M-2.47M-1.32M-1.95M-368K-571K
CapEx % of Revenue2.28%2.56%3.8%2.68%1.9%1.26%1.26%3.24%3.22%3.33%1.73%1.32%2.15%2.2%3.33%2.94%1.79%3.02%0.6%1.1%
Acquisitions000000-8.2M-393.08M0000000000-84.49M0
Investments--------------------
Other Investing-9.13M-5.25M7.98M-60K-2.9M-17.37M-86K-631K013.51M-2.5M-2.81M-4.33M-4K-4K-7.35M717K-229K2.65M-12K
Cash from Financing-4.65M-21.62M-4.64M6.34M-1.75M-9.91M-4.91M291.03M-1.45M-19.73M-11.92M3.75M80.15M-4.55M-508K-911K-1.44M-2.27M179.44M-3.02M
Debt Issued (Net)-4.06M-4.06M-4.06M-2.03M-2.03M-2.03M36.57M292.8M-750K-750K-750K-750K-750K-750K-750K-750K-750K-750K83.32M-2.83M
Equity Issued (Net)-505K-17.55M-573K8.75M-9.31M-10M1.38M512K-295K-8.66M-231K081.31M-3.55M-119K-239K-483K-1.12M96.32M-73K
Dividends Paid000-344K-407K-406K-406K-406K-407K-406K-406K-406K-407K-406K-407K-406K-407K-405K-190K0
Share Repurchases-813K-19.75M-611K-1.04M0-10M-318K-680K-1.3M-8.66M-231K0-537K-3.55M-119K-239K-483K-1.12M-1K-73K
Other Financing-80K00-26K10M2.53M-42.45M-1.88M0-9.91M-10.53M4.91M0157K768K484K203K3K0-121K
Net Change in Cash49.03M25.59M22.98M44.81M68M4.94M-123K-95.09M11.51M7.48M28.04M31.37M93.95M14.52M-8.05M-7.1M-13.53M-23.39M85.05M-9.01M
Free Cash Flow67.99M47.05M6.51M37.89M68.9M15.14M13.38M7.66M12.96M13.69M39.96M27.62M13.8M19.07M-7.54M-6.19M-12.8M-21.12M-12.55M-5.99M
FCF Margin %25.56%19.81%2.63%16.63%32.6%7.68%7.02%5.17%9.39%9.96%30.35%20.95%11.84%17.86%-8%-7.39%-17.34%-32.76%-20.6%-11.5%
FCF Growth %-1.32%210.67%-51.37%394.54%431.45%10.64%-66.52%-72.26%-6.05%-28.23%629.85%546.07%207.77%190.3%39.92%-3.44%41.02%-205.97%-60.36%19.37%
FCF per Share3.102.180.311.803.390.760.690.390.670.702.081.440.771.15-0.46-0.38-0.79-1.31-0.88-0.49
FCF Conversion (FCF/Net Income)2.29x1.98x1.10x1.83x8.87x2.23x-1.54x-0.52x-7.61x1.00x38.74x3.24x3.30x14.89x1.04x-0.42x0.77x0.94x0.50x1.21x
Interest Paid004.61M8.46M4.97M8.89M5.15M3.08M8.21M7.95M8.01M7.97M11.16M4.29M7.45M2.63M5.76M5.64M3.78M1.97M
Taxes Paid001.06M140K16.19M285K1.85M016.35M852K298K789K-2.6M2.74M132K32K124K02.01M0